Shuang Wen Zhang
Directeur/Membre du Conseil chez Xiamen LP Pharmaceutical Co., Ltd.
Postes actifs de Shuang Wen Zhang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Directeur/Membre du Conseil | 13/11/2020 | - |
Historique de carrière de Shuang Wen Zhang
Anciens postes connus de Shuang Wen Zhang
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | 15/07/2018 | - |
Formation de Shuang Wen Zhang
Xiamen University | Doctorate Degree |
Statistiques
Internationale
Chine | 4 |
Opérationnelle
Director/Board Member | 2 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Commercial Services |
- Bourse
- Insiders
- Shuang Wen Zhang
- Expérience